Revenue

onsemi will detail its long-term financial and innovation roadmap, focusing on capitalizing on AI, EV, and industrial megatrends amid fierce competition.

Following strong Q4 earnings, Datadog will detail its AI and cloud strategy at a major conference, with investors and tech leaders watching closely.

After a major trial miss sent its stock tumbling, GRAIL will face investors to pitch its vision for the future of early cancer detection technology.

Euroholdings declared a dividend on solid Q4 results, but a $10.2M one-time gain skews its full-year profits as it bets big on the tanker market.

Latin American giant MercadoLibre posts record revenue for 2025 but misses profit estimates, sending shares lower as it invests heavily in future growth.

The beloved Marin grocer announces its third store, creating 200+ jobs and serving as a key player in the Northgate Mall's ambitious transformation.

LexisNexis integrates Anthropic's powerful Legal Plugin, escalating the AI arms race and promising a new era of automated, verifiable legal work.

Sirion's recognition by The Hackett Group validates its AI-native approach, signaling a major shift in enterprise procurement and contract management.

Local entrepreneurs launch a new Spray-Net franchise in Allen, offering a patented, factory-finish alternative to traditional home painting and replacement.

Knights of Columbus Asset Advisors appoints fintech expert Deepak Devaraj to lead its $30B fund, signaling a new era for faith-based investing.

A new national research initiative will explore how AI can help universities scale online programs without sacrificing quality, focusing on human-AI collaboration.

New research shows employees bypass learning platforms for managers. Go1's new tool empowers managers to fund real-world development beyond eLearning.

A Florida jury found Publix 100% liable for a fall that led to three spinal surgeries for a young mother, rejecting the company's $600k offer.

With $3M in new funding, Kris@Work is building an AI-native platform to replace fragmented sales tools and end the era of enterprise SaaS fatigue.

Nabsys's electronic genome mapping reveals how rogue genetic elements damage our DNA, opening new frontiers in understanding cancer and neurodegeneration.

A new Ontario program is giving breast cancer patients access to a life-changing drug a year sooner, setting a potential new standard for Canada.

A new solar-powered detection trailer offers a flexible, data-driven weapon against a rising tide of wrong-way crashes on America’s highways.

As remote work and fuel costs rise, companies are turning everyday minivans into versatile adventure vehicles, challenging the traditional RV market.

With $6.9M in total funding, the UMass spin-out is set to disrupt AR and AI markets with its durable, all-inorganic nano-imprinted optical components.

A newly identified blood biomarker for the drug masitinib could revolutionize how doctors treat ALS, progressive MS, and Alzheimer's disease.